About William Martinez Zegarra
Form D filings for Avalor Therapeutics in 2023 list William Martinez Zegarra as president and director.
William Martinez Zegarra first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name William Martinez Zegarra in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Martinez Zegarra works with at each company, as listed on that company's latest Form D.
Avalor Therapeutics, Inc. · Form D, Dec 5, 2023
AF
Anthony Ford
Director
KW
Kenneth Wild
Director